[ad_1]
Celltrion Group announced plans to merge three companies, Celltrion, Celltrion Healthcare and Celltrion Pharmaceutical.
First, Celltrion Healthcare Holdings was established on the 25th in preparation for the merger of the three companies. Celltrion Healthcare Holdings was established by investing in cash shares held by Chairman Seo Jeong-jin, the largest shareholder in Celltrion Healthcare.
Celltrion explained that it is a job to separate ownership from management and strengthen governance. It is planning to establish a Celltrion Group holding company system by the end of 2021 by promoting the merger of Celltrion Holdings and Celltrion Healthcare Holdings immediately after the qualified merger requirements are met.
The merger of the three companies will be promoted promptly when the requirements to restrict the conduct of holding companies in the ‘Monopoly Regulation and Fair Trade Law’ are met.
Celltrion Group explains that by establishing a portfolio company system through the establishment of these health farms, it is possible to ensure a professional management system by separating ownership and management.
Furthermore, since the three companies were merged, development, production, distribution and sales are carried out simultaneously by a single company, it is also expected to reduce costs and improve business transparency through better transaction structures. .
Celltrion Group expects the company’s business capabilities to expand significantly to compete with global Big Pharma. In the global biopharmaceutical market, it is necessary to become a pharmaceutical company with a scale to compete with the large global pharmaceutical companies that have put capital and scale ahead.
If the three companies merge, a large-scale pharmaceutical company with drug research / development, marketing, and direct sales distribution network will be created, which is expected to have greater influence and competitiveness in the global market.
When a competitive portfolio of important products such as biopharmaceuticals and chemicals is formed within the group and presented to the national and international markets, it is expected to contribute to the quantitative and qualitative growth of efficiency in terms of sales volume and unified sales channels.
A Celltrion Group official said: “I believe this merger is an effective way to enhance the Celltrion Group’s competitiveness while enhancing transparency in business operations.” As a result, it will grow. “
[소비자가만드는신문=유성용 기자]
Copyright holder © Unauthorized reproduction and redistribution of newspapers by consumers is prohibited
